Assessment of Birth Outcomes in Eswatini after Transition to Dolutegravir-based Treatment

The aim of this ViiV-funded observational study is to evaluate the birth outcomes of HIV-positive women who are receiving Dolutegravir or other ARV drug regimens in Eswatini.

Data Collection Period: 09/2021 – 09/2022